Jody C Rhames, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 777 Kimole Ln, Suite 230, Adrian, MI 49221 Phone: 517-263-5655 Fax: 517-263-8012 |
Don E Keener, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 777 Kimole Ln, Suite 230, Adrian, MI 49221 Phone: 517-263-5655 Fax: 517-263-8012 |
Tariq A. Siddiqi, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 755 High St, Adrian, MI 49221 Phone: 517-265-2175 Fax: 517-264-5926 |
Manishkumar Patel, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 781 Lakeshire Trl, Adrian, MI 49221 Phone: 517-265-0600 |
Dr. Aron Alan Gornowicz, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 146 South Charles Street, Adrian, MI 49221 Phone: 517-366-5000 Fax: 517-366-5002 |
Dr. Josephine A Pabalan, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 818 Riverside Ave, Adrian, MI 49221 Phone: 517-265-0900 Fax: 989-340-1214 |
Paul J Lentz Jr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 777 Kimole Ln, Suite 230, Adrian, MI 49221 Phone: 517-263-5655 Fax: 517-263-8012 |
Amy Hammond, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3245 N Adrian Hwy Ste A, Adrian, MI 49221 Phone: 517-366-5010 Fax: 517-366-5014 |
Dr. Sudha Bansal, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 415 Mill Rd, Adrian, MI 49221 Phone: 517-264-5820 |
News Archive
Giving clinicians a more complete picture while improving safety during interventional procedures, Toshiba America Medical Systems, Inc. introduces Spot Fluoroscopy for its Infinix-i systems.
A leading British expert on eating disorders has warned that the current obsession with size-zero in the fashion industry is encouraging women to 'famine then feast'.
New research shows that women who have fertility problems are 18 percent more likely to develop ovarian and endometrial or womb cancers in later life.
Celsion Corporation, a biotechnology drug development company, today announced financial results for the second quarter and six months ended June 30, 2010 and addressed the progression of the clinical trials of ThermoDox, Celsion's heat activated liposomal encapsulation of doxorubicin. ThermoDox is currently being evaluated in the Phase III HEAT trial for the treatment of hepatocellular carcinoma and in a Phase I/II trial for patients with recurrent chest wall breast cancer.
› Verified 8 days ago